InsideArbitrage Event Driven Monitor – March 9, 2026

Note: You can click on any section title to jump straight to the related tool or page. Merger Arbitrage DAWN: The acquisition of Day One Biopharmaceuticals, Inc. (DAWN) by Servier for a closing value of $2.5 billion. Servier will commence a cash tender offer to acquire all of the issued and outstanding shares of Day